间歇性肺压缩可能减少肌肉疼痛,但在运动诱导的肌肉损伤后不会改善神经肌肉功能:一个随机的安慰剂受控试验
Filipe Maia1, Fábio Y Nakamura1, Ricardo Pimenta2,3,4,5
1Research Center in Sports Sciences, Health Sciences and Human Development (CIDESD), University of Maia, Maia, Portugal.
概括
间歇性气动压缩 (IPC) 没有提高运动员在强度炼后的恢复. 虽然它显示出减少肌肉疼痛的趋势,但它没有改善跳跃或最大自愿收缩等性能指标.
科学领域:
- 运动科学 运动科学 运动科学
- 运动生理学 运动生理学
- 康复 康复 康复 康复
背景情况:
- 运动引起的肌肉损伤 (EIMD) 是强烈体力活动的常见后果.
- 有效的恢复策略对于运动员恢复表现和最大限度地减少不适至关重要.
- 间歇性气压 (IPC) 是一种恢复方式,对肌肉的修复和功能有潜在的益处.
研究的目的:
- 为了评估30分钟间歇性气压压缩 (IPC) 协议在艰苦运动后恢复动力学上的有效性.
- 评估IPC对功能表现和运动诱导肌肉损伤后感知到的肌肉疼痛的影响.
主要方法:
- 33名活跃的男性大学生参与了这项研究.
- 参与者接受了一项全力以赴的飞轮坐方案,以诱导肌肉损伤.
- 进行随机分配,进行30分钟的IPC治疗 (200 mm Hg) 或安慰剂干预.
- 干预前和后 (立即,24小时,48小时) 进行了功能测试 (例如跳跃,最大膝盖伸展/屈曲) 和疼痛问卷.
主要成果:
- 在所有运动后的测量中都证实了显著的疲劳 (ηp2: .216.697;P < .05).
- 在IPC和安慰剂组之间没有发现性能恢复的统计学上显著差异 (ηp2: .001.130; P: .155.859).
- 在IPC中观察到减少感知疼痛的趋势,表明潜在的实际相关性 (d:0.320.75).
结论:
- 运动后立即进行30分钟的IPC应用并不能显著改善跳跃恢复或最大自发收缩性能.
- 在减少感知到的肌肉疼痛方面,IPC可能会带来实际好处,这需要进一步的研究.
- 这些发现表明,虽然IPC可能不会增强体能恢复,但其对主观疼痛的影响需要在运动群体中继续调查.
相关概念视频
Skeletal Muscle Relaxants: Therapeutic Uses
632
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
632
Skeletal Muscle Relaxants: Adverse Effects
485
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
485
Classification of Skeletal Muscle Relaxants
2.7K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.7K
Muscle Stimulation Frequency
2.7K
The contraction strength of muscles is regulated by motor neurons, which modulate the frequency of action potentials dispatched to the motor units based on the body's requirements. This process of varying the muscle stimulation frequency allows muscles to contract with a force that is precisely tailored to the needs of the moment, whether lifting a feather or a heavy box.
Wave summation
At low firing rates, motor neurons induce individual twitch contractions in muscle fibers. These twitches...
Wave summation
At low firing rates, motor neurons induce individual twitch contractions in muscle fibers. These twitches...
2.7K
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
774
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
774
Peripheral Artery Disease III: Interprofessional Care
34
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
34


